These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17695488)

  • 1. Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study.
    Mambrini A; Guglielmi A; Pacetti P; Iacono C; Torri T; Auci A; Nicoli N; Orlandi M; Guadagni S; Fiorentini G; Cantore M
    Anticancer Res; 2007; 27(4C):3009-13. PubMed ID: 17695488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
    Cantore M; Mambrini A; Fiorentini G; Rabbi C; Zamagni D; Caudana R; Pennucci C; Sanguinetti F; Lombardi M; Nicoli N
    Cancer; 2005 Apr; 103(7):1402-7. PubMed ID: 15726542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma.
    Park SH; Park YH; Lee JN; Bang SM; Cho EK; Shin DB; Lee JH
    Cancer; 2006 Jan; 106(2):361-5. PubMed ID: 16342166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.
    Hong YS; Lee J; Lee SC; Hwang IG; Choi SH; Heo JS; Park JO; Park YS; Lim HY; Kang WK
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):321-8. PubMed ID: 17143602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-arterial and systemic chemotherapy plus external hyperthermia in unresectable biliary cancer.
    Mambrini A; Del Freo A; Pacetti P; Orlandi M; Torri T; Fiorentini G; Cantore M
    Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):805-6. PubMed ID: 17892927
    [No Abstract]   [Full Text] [Related]  

  • 6. Regional combined with systemic chemotherapy in unresectable biliary tract cancers: a phase II study.
    Cantore M; Fiorentini G; Mambrini A; Rabbi C; Zamagni D; Carlone N; Manni A; Caudana R; Torri T
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):59-64. PubMed ID: 16767908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
    Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Kim HB; Hong EK; Park JW; Kim CM
    Chemotherapy; 2012; 58(3):225-32. PubMed ID: 22831988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of cisplatin, epirubicin and continuous infusion of 5-fluorouracil in patients with advanced intrahepatic cholangiocellular carcinoma (ICC).
    Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
    Hepatogastroenterology; 2008; 55(85):1380-4. PubMed ID: 18795694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer.
    Cho EK; Lee WK; Im SA; Lee SN; Park SH; Bang SM; Park DK; Park YH; Shin DB; Lee JH
    Oncology; 2005; 68(4-6):333-40. PubMed ID: 16020960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nucleotide polymorphisms and clinical outcome in patients with biliary tract carcinoma treated with epirubicin, cisplatin and capecitabine.
    Pacetti P; Giovannetti E; Mambrini A; Nannizzi S; Orlandi M; Tartarini R; Del Freo A; Del Tacca M; Danesi R; Cantore M
    Anticancer Res; 2009 May; 29(5):1835-40. PubMed ID: 19443413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine, epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinoma.
    Corporaal S; Smit WM; Russel MG; van der Palen J; Boot H; Legdeur MC
    Neth J Med; 2006 May; 64(5):141-6. PubMed ID: 16702612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
    Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
    Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer.
    Yun J; Lee J; Park SH; Park JO; Park YS; Lim HY; Kang WK
    Eur J Cancer; 2010 Mar; 46(5):885-91. PubMed ID: 20060288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of capecitabine plus cisplatin in patients with gastric cancer.
    Salah-Eldin MA; Ebrahim MA; AL-Ashry MS
    Anticancer Drugs; 2009 Mar; 20(3):191-6. PubMed ID: 19396018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.
    Li YH; Wang FH; Jiang WQ; Xiang XJ; Deng YM; Hu GQ; Xu DM; Chen Y; Lin Q; He YJ
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):539-44. PubMed ID: 18172651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival.
    Bamias A; Hill ME; Cunningham D; Norman AR; Ahmed FY; Webb A; Watson M; Hill AS; Nicolson MC; O'Brien ME; Evans TC; Nicolson V
    Cancer; 1996 May; 77(10):1978-85. PubMed ID: 8640659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinoma.
    Pluschnig U; Schoppmann SF; Preusser M; Datler P; Asari R; Ba-Ssalamah A; Schwameis K; Birner P; Zacherl J; Hejna M
    Anticancer Res; 2013 Mar; 33(3):1035-9. PubMed ID: 23482778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer.
    Villman K; Ohd JF; Lidbrink E; Malmberg L; Lindh B; Blomqvist C; Nordgren H; Bergh J; Bergström D; Ahlgren J
    Eur J Cancer; 2007 May; 43(7):1153-60. PubMed ID: 17398088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.
    Lee SS; Lee JL; Ryu MH; Chang HM; Kim TW; Kang HJ; Kim WK; Lee JS; Kang YK
    Jpn J Clin Oncol; 2007 Jan; 37(1):30-7. PubMed ID: 17272321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.